Patents by Inventor William J. Callahan

William J. Callahan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-TNF ALPHA ANTIBODY FORMULATIONS
    Publication number: 20230151086
    Abstract: Stable adalimumab formulations are disclosed.
    Type: Application
    Filed: August 19, 2022
    Publication date: May 18, 2023
    Applicant: Amgen Inc.
    Inventors: William J. CALLAHAN, Rahul Rajan KAUSHIK, Joy BRENNAN
  • Reduced viscosity protein pharmaceutical formulations
    Patent number: 11459401
    Abstract: Described herein are therapeutic protein formulations comprising N-methyl pyrrolidone (NMP), methods related to reducing viscosity of pharmaceutical formulations and methods related to stabilizing pharmaceutical formulations using NMP.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: October 4, 2022
    Assignee: Amgen Inc.
    Inventors: Alona Teran, Qahera Munaim, Nazer Khalaf, Rahul Rajan Kaushik, Christi L. Clogston, Twinkle R. Christian, William J. Callahan
  • VEGFR-FC FUSION PROTEIN FORMULATIONS
    Publication number: 20200338164
    Abstract: Protein formulations and methods of making and using such formulations are provided herein. The formulation can be an ophthalmic formulation, such as for intravitreal administration. In some embodiments, the formulation comprises a VEGFR-Fc fusion protein, such as aflibercept.
    Type: Application
    Filed: November 16, 2018
    Publication date: October 29, 2020
    Applicant: AMGEN INC.
    Inventors: Yael WEXLER-COHEN, William J. CALLAHAN, Robert Matthew FESINMEYER, Rahul Rajan KAUSHIK, Sai Chakradhar PADALA
  • ANTI-TNF ALPHA ANTIBODY FORMULATIONS
    Publication number: 20200087390
    Abstract: Stable adalimumab formulations are disclosed.
    Type: Application
    Filed: December 20, 2017
    Publication date: March 19, 2020
    Applicant: AMGEN INC.
    Inventors: William J. CALLAHAN, Rahul Rajan KAUSHIK, Joy BRENNAN
  • REDUCED VISCOSITY PROTEIN PHARMACEUTICAL FORMULATIONS
    Publication number: 20200024363
    Abstract: Described herein are therapeutic protein formulations comprising N-methyl pyrrolidone (NMP), methods related to reducing viscosity of pharmaceutical formulations and methods related to stabilizing pharmaceutical formulations using NMP.
    Type: Application
    Filed: October 6, 2017
    Publication date: January 23, 2020
    Inventors: Alona Teran, Qahera Muniam, Nazer Khalaf, Rahul Rajan Kaushik, Christi L. Clogston, Twinkle R. Christian, William J. Callahan
  • Lyophilized therapeutic peptibody formulations
    Patent number: 10166189
    Abstract: The present invention provides long-term stable formulations of a lyophilized therapeutic peptibody and methods for making a lyophilized composition comprising a therapeutic peptibody.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: January 1, 2019
    Assignee: AMGEN INC.
    Inventors: William J. Callahan, Richard L. Remmele, Jr., Gayathri Ratnaswamy, Ramil F. Latypov, Dingjiang Liu
  • LYOPHILIZED THERAPEUTIC PEPTIBODY FORMULATIONS
    Publication number: 20160143852
    Abstract: The present invention provides long-term stable formulations of a lyophilized therapeutic peptibody and methods for making a lyophilized composition comprising a therapeutic peptibody.
    Type: Application
    Filed: January 29, 2016
    Publication date: May 26, 2016
    Applicant: AMGEN INC.
    Inventors: William J. CALLAHAN, Richard L. REMMELE, Jr., Gayathri RATNASWAMY, Ramil F. LATYPOV, Dingjiang LIU
  • Lyophilized therapeutic peptibody formulations
    Patent number: 9283260
    Abstract: The present invention provides long-term stable formulations of a lyophilized therapeutic peptibody and methods for making a lyophilized composition comprising a therapeutic peptibody.
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: March 15, 2016
    Assignee: AMGEN INC.
    Inventors: William J. Callahan, Richard L. Remmele, Jr., Gayathri Ratnaswamy, Ramil F. Latypov, Dingjiang Liu
  • Lyophilized therapeutic peptibody Formulations
    Publication number: 20090258017
    Abstract: The present invention provides long-term stable formulations of a lyophilized therapeutic peptibody and methods for making a lyophilized composition comprising a therapeutic peptibody.
    Type: Application
    Filed: April 19, 2007
    Publication date: October 15, 2009
    Inventors: William J. Callahan, Richard L. Remmele, JR., Gayathri Ratnaswamy, Ramil F. Latypov, Dingjiang Liu
  • Method of authenticating products using analog and digital identifiers
    Patent number: 7364074
    Abstract: A method of identifying or authenticating a product by providing an analog identification indicium including a randomized pattern of identification features on a first part of the product wherein one or more attributes of the randomized pattern of identification features correspond to an item identifier. A digital identification record is provided on a second part of the product including an encoded digital version of the item identifier, the first and second parts being separable when the product is used. The randomized pattern of identification features of the analog identification indicium is read and decoded to generate an item identifier and the digital identification record is read and decoded to generate an item identifier. The product is deemed authentic if the item identifier from the analog identification indicium substantially matches the item identifier from the digital identification record.
    Type: Grant
    Filed: January 19, 2005
    Date of Patent: April 29, 2008
    Assignee: Symbol Technologies, Inc.
    Inventors: Duanfeng He, William J. Callahan